Curaleaf Holdings (CURLF) Receivables (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Receivables of $79.0 million for Q4 2025, up 14.84% year-over-year from $68.8 million in Q4 2024, and up 14.84% quarter-over-quarter from $68.8 million in Q4 2024.
Curaleaf Holdings (CURLF) Receivables (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Receivables history runs 7 years deep, the most recent figure standing at $79.0 million for Q4 2025.
- In Q4 2025, Receivables rose 14.84% year-over-year to $79.0 million; the TTM figure through Dec 2025 stood at $79.0 million (up 14.84% YoY), while the FY2025 annual figure was $81.4 million, up 15.03% from the prior year.
- Receivables for Q4 2025 stood at $79.0 million, up from $68.8 million in the prior quarter.
- The five-year high for Receivables was $66.8 billion in Q1 2022, with the low at -$6.2 million in Q3 2022.
- The 5-year median for Receivables is $53.2 million (2021), against an average of $5.6 billion.
- Peak annual rise in Receivables reached 1670225100.0% in 2022, while the deepest fall reached 110.93% in 2022.
- Curaleaf Holdings' Receivables stood at $2.4 million in 2021, then slumped by 355.86% to -$6.2 million in 2022, then surged by 1035.81% to $58.0 million in 2023, then climbed by 18.46% to $68.8 million in 2024, then rose by 14.84% to $79.0 million in 2025.
- Business Quant data shows CURLF's Receivables at $79.0 million in Q4 2025, $68.8 million in Q4 2024, and $58.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 81.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.19 Mn |
| Dec 31, 2025 | 78.96 Mn |
| Dec 31, 2024 | 68.75 Mn |
| Dec 31, 2023 | 58.04 Mn |
| Sep 30, 2023 | 5.61 Mn |
| Jun 30, 2023 | 46.67 Mn |
| Sep 30, 2022 | -6.20 Mn |
| Jun 30, 2022 | 64.65 Mn |
| Mar 31, 2022 | 66.81 Bn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 56.76 Mn |
| Jun 30, 2021 | 49.67 Mn |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | -14.10 Mn |
| Mar 31, 2020 | -14.60 Mn |
| Dec 31, 2019 | -35.44 Mn |
| Sep 30, 2019 | -24.00 Mn |